A rapid diagnostic test for Ebola has been developed by Swiss pharmaceutical group Roche and hopes to obtain fast-tract US approval for it. The company's director general declared this in an interview published Sunday, amid the worst-ever outbreak of the killer disease. The diagnostic test is ready for use in scientific research but the company now wants to register it for clinical use. Roche has filed for European Union approval of the test and plans ...
via Medindia Health News
More READ 
Lake forest health and fitness http://ift.tt/12NEHYj
No comments:
Post a Comment